Fu-chun Huo
209 Tong Shan Road
Xuzhou, 221004, China
Xuzhou, 221004, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
METTL3-mediated m6A modification of PAK6 drives cervical cancer progression through activating MAPK14.
Journal: International journal of biological macromolecules
Published: March 04, 2025
Crosstalk between m6A modification and alternative splicing during cancer progression.
Journal: Clinical and translational medicine
Published: May 30, 2023
HPV E7-drived ALKBH5 promotes cervical cancer progression by modulating m6A modification of PAK5.
Journal: Pharmacological research
Published: March 22, 2023
Alternative splicing of HSPA12A pre-RNA by SRSF11 contributes to metastasis potential of colorectal cancer.
Journal: Clinical and translational medicine
Published: August 28, 2022
Author Correction: Rap2a serves as a potential prognostic indicator of renal cell carcinoma and promotes its migration and invasion through up-regulating p-Akt.
Journal: Scientific reports
Published: July 16, 2021
PAK5-stabilized Smuc confers renal cell carcinoma metastasis.
Journal: Clinical and translational medicine
Published: May 28, 2021
MicroRNA-138-1-3p sensitizes sorafenib to hepatocellular carcinoma by targeting PAK5 mediated β-catenin/ABCB1 signaling pathway.
Journal: Journal of biomedical science
Published: January 17, 2021
METTL3-mediated m6A methylation of SPHK2 promotes gastric cancer progression by targeting KLF2.
Journal: Oncogene
Published: September 27, 2020
Epidermal growth factor-like domain multiple 6 (EGFL6) promotes the migration and invasion of gastric cancer cells by inducing epithelial-mesenchymal transition.
Journal: Investigational new drugs
Published: August 06, 2020
N6 -methyladenosine (m6A) RNA modification in human cancer.
Journal: Cell proliferation
Published: July 10, 2020
Last Updated: 09/26/2026